Paul Offit

In a Pediatrics article on the capacity of the infant immune system, Paul Offit and his co-authors used a theoretical calculation to explain that an infant would have sufficient immunological capacity to respond simultaneously to a very large number of vaccines, approximately 10,000. The figure was subsequently frequently taken out of context and presented as though Offit were actually recommending the administration of thousands of vaccines.

State of the evidence

Documented

Attribution

Directly implicated

Following Health Secretary Robert F. Kennedy Jr.'s announcement of rapid changes to COVID recommendations for healthy children and pregnant women, Offit co-authored a critique in JAMA denouncing a departure from the usual scientific review and advisory deliberation process.

State of the evidence

Documented

Attribution

Directly implicated

In autumn 2025, Offit ceased serving on the FDA vaccine advisory committee. HHS stated that his term as a special government employee had expired; Offit maintained, by contrast, that the FDA had asked him to remain for two further years, that the paperwork had been completed and that renewal had subsequently been blocked at HHS level without explanation.

State of the evidence

Documented

Attribution

Direct responsibility

Offit argued that an identical annual COVID booster campaign for the entire population was not well justified for healthy young adults, whose protection against severe disease remained high. He advocated prioritising older, immunocompromised or vulnerable people.

State of the evidence

Documented

Attribution

Directly implicated

Offit was one of two members of the FDA advisory committee to vote against switching to bivalent COVID-19 boosters targeting Omicron in June 2022. He subsequently stated that human data had been too limited at the time of the decision and that the additional benefit had been 'grossly oversold' in public communications.

State of the evidence

Documented

Attribution

Close aide

In September 2021, Offit opposed immediately offering a third COVID-19 vaccine dose to all adults, considering that the evidence mainly supported boosters for older people or those at high risk. The debate was politically sensitive because the Biden administration had already announced a broader booster campaign.

State of the evidence

Documented

Attribution

Close aide

Following publication of an article in JAMA, Offit acknowledged that his initial conflict-of-interest declaration had not mentioned all his historical links with vaccines, notably his status as co-inventor and co-owner of the RotaTeq patent and earlier interests linked to the Wistar Institute. JAMA published a clarification.

State of the evidence

Documented

Attribution

Directly implicated

Barbara Loe Fisher, a vaccine critic, sued Offit after he stated in Wired that she 'lies' about vaccines. She sought one million dollars in damages. In March 2010, the federal court dismissed the action, finding that, in the context of a highly contentious public debate, the disputed wording did not constitute an actionable defamatory assertion.

Attribution

Accused

Offit co-invented technology that led to the rotavirus vaccine RotaTeq and co-owned patents from which he and his institution received royalties. Reports also highlighted his former role as a scientific adviser to Merck and the fact that the Children's Hospital of Philadelphia had sold its future royalty interests for 182 million dollars. These relationships fuelled recurring allegations that his vaccine advocacy was financially motivated.

State of the evidence

Documented